A British mother reveals how the diabetes drug Mounjaro transformed her life, helping her lose over five stone and break a debilitating shopping addiction, saving her thousands of pounds in the process.
Exclusive analysis reveals NHS Scotland's staff sickness rates have soared to their highest level in 10 years, with 18 out of 18 health boards reporting increased absenteeism, raising alarm about workforce burnout and patient care.
Novo Nordisk has announced significant price cuts for its popular weight-loss and diabetes drugs, Ozempic and Wegovy, making them more accessible to patients across the UK.
Discover how to transition from Mounjaro to Wegovy safely and avoid weight regain, as explained by a leading GP. Plus, why the 'King Kong' jab could triple in price.
A recent study suggests that popular weight loss drugs Ozempic and Wegovy, containing semaglutide, may increase the risk of a rare eye condition leading to vision loss. Experts urge caution.
Dozens of NHS trusts are under pressure to cut costs after the Department of Health and Social Care ordered urgent savings, raising concerns over patient care.
Pharmaceutical giant Eli Lilly is developing an oral weight loss drug that may compete with injectable treatments like Wegovy. Early trials show promising results, potentially offering a more convenient alternative for patients.
Pharmaceutical giant Eli Lilly warns of potential shortages for its diabetes and weight-loss drug Mounjaro in Canada, as demand skyrockets following its approval for obesity treatment.
A groundbreaking weight loss pill, Orforglipron, shows promise in clinical trials, potentially offering an effective alternative to Wegovy for obesity management.
A 49-year-old mother shares her harrowing experience with weight loss injections, warning others after suffering severe side effects including black urine and hospitalisation.
New research suggests that weight loss injections like Wegovy may lead to significant weight regain once discontinued, raising concerns about long-term effectiveness.
The NHS is expanding access to obesity treatments Mounjaro and Wegovy, making them available in local pharmacies following approval by NICE.
New research warns that patients who stop taking weight-loss injections like Wegovy may regain most of the lost weight, raising concerns about long-term effectiveness.
A new survey reveals that two in five Brits secretly suspect their friends are using weight loss injections but are too afraid to ask.
New figures reveal NHS waiting lists have surged to a staggering 7.57 million, with patients facing agonising delays for specialist care. Experts warn the crisis is far from over.
Renowned chef Heston Blumenthal warns that slimming injections like Wegovy could disrupt the food industry, raising questions about health trends and culinary innovation.
A recent report highlights severe staffing shortages within the NHS, raising concerns over patient care and service sustainability. Experts warn of growing pressures on healthcare workers.
Novo Nordisk's blockbuster weight-loss drug Wegovy drives record sales, boosting shares and intensifying competition with Eli Lilly.
The US obesity epidemic has led to soaring demand for Wegovy, a weight-loss injection containing semaglutide. Experts warn of supply shortages as prescriptions surge.
Groundbreaking research suggests the NHS could save significant costs by prescribing Wegovy for weight loss, reducing obesity-related illnesses.
Discover how diabetes medications like Mounjaro and Ozempic are being repurposed as revolutionary weight loss treatments, sparking global demand and ethical debates.
New research indicates that weight loss injections such as Ozempic and Wegovy may revolutionise obesity management, offering hope for millions struggling with weight-related health issues.
A major UK supermarket has introduced a controversial £129 monthly weight-loss injection service, sparking backlash from customers questioning its affordability and ethics.
New research reveals that weight loss injections like Mounjaro and Wegovy are proving highly effective for Generation X, offering hope in the battle against obesity.
Experts warn that two widely used weight loss injections may face restrictions in the UK due to safety concerns. Here’s the latest on the potential ban and alternatives.
New research reveals that weight loss injections like Mounjaro and Wegovy offer significant health benefits, including reduced risk of heart disease and diabetes, beyond just aiding weight reduction.
UK doctors are striking once more over pay and working conditions, deepening the NHS crisis. Here’s why they’re walking out and what it means for patients.
Breakthrough research suggests that popular weight loss injections like Wegovy and Ozempic may significantly reduce the risk of cardiovascular events, offering hope for millions.
New research reveals that popular weight-loss medications Wegovy and Mounjaro may increase the risk of severe stomach and intestinal problems, including paralysis and pancreatitis.
The NHS is set to provide Wegovy and Mounjaro, groundbreaking weight-loss medications, following new evidence of their health benefits beyond obesity treatment.